首页 | 本学科首页   官方微博 | 高级检索  
     


Mast cell degranulating peptide binds to RBL-2H3 mast cell receptors and inhibits IgE binding
Authors:Angeliki Buku   Joseph A. Price   Milton Mendlowitz  Sandra Masur
Affiliation:

a Department of Physiology and Biophysics, Mount Sinai School of Medicine, New York, NY 10029, USA

b Department of Pathology, College of Osteopathic Medicine, Oklahoma State University, Tulsa, OK 74107, USA

c Department of Molecular Cardiology, Mount Sinai School of Medicine, New York, NY 10029, USA

d Departments of Ophthalmology and Physiology and Biophysics, Mount Sinai School of Medicine, New York, NY 10029, USA

Abstract:Fluorescent and biotinylated analogs of mast cell degranulating (MCD) peptide were synthesized and the labels fluoresceinisothiocyanate and N-hydroxysuccinimidobiotin were conjugated at position 1 in the MCD peptide sequence. The analogs with these moieties retained histamine-releasing activity as high as that of the parent MCD peptide in rat peritoneal mast cell assays. These labeled analogs were used in rat basophilic leukemia cells (RBL-2H3) to demonstrate by confocal microscopy and flow cytometry the specific binding of MCD peptide to mast cell receptors. Consequently MCD peptide was found to compete with and inhibit the binding of fluorescent IgE on RBL cells as monitored by flow cytometry. Thus MCD peptide may prove to be useful in the study of IgE receptor-bearing cells.
Keywords:Fluorescent and biotinylated MCD peptide   Flow cytometry   Confocal microscopy   Fluorescent IgE
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号